1.Boswell-Smith V, Spina D, Oxford AW, Comer MB, Seeds EA, Page CP. (2006) The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one].. J Pharmacol Exp Ther, 318 (2):(840-8). [PMID:16682455]
2.Venkatasamy R, Spina D. (2016) Novel relaxant effects of RPL554 on guinea pig tracheal smooth muscle contractility.. Br J Pharmacol, 173 (15):(2335-51). [PMID:27174172]
3.Turner MJ, Dauletbaev N, Lands LC, Hanrahan JW. (2020) The Phosphodiesterase Inhibitor Ensifentrine Reduces Production of Proinflammatory Mediators in Well Differentiated Bronchial Epithelial Cells by Inhibiting PDE4.. J Pharmacol Exp Ther, 375 (3):(414-429). [PMID:33012706]
4.Singh D, Abbott-Banner K, Bengtsson T, Newman K. (2018) The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.. Eur Respir J, 52 (5):(589-97). [PMID:30166326]
5.Cazzola M, Page C. (2018) An inhaled "bifunctional" dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD.. Eur Respir J, 52 (5):(589-97). [PMID:30385603]
6.Bjermer L, Abbott-Banner K, Newman K. (2019) Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma.. Pulm Pharmacol Ther, 58 (3):(101814). [PMID:31202957]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
